RecruitingNCT05386615

Post-Exablate Pregnancy Outcomes Registry Study: Exablate Treatment of Symptomatic Uterine Fibroids


Sponsor

InSightec

Enrollment

200 participants

Start Date

Feb 16, 2016

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this Registry Study is to capture clinical pregnancy outcomes and fibroid treatment background data for any subject post-Exablate treatment for their symptomatic fibroids.


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 50 Years

Plain Language Summary

Simplified for easier understanding

This registry study is tracking pregnancy outcomes in women who previously had their uterine fibroids treated with a non-surgical procedure called Exablate focused ultrasound, which uses sound wave energy directed at fibroids to shrink them without any incisions. The goal is to understand the long-term effects on fertility and pregnancy after this treatment. **You may be eligible if...** - You have had your uterine fibroids treated with the Exablate focused ultrasound system - You have consented to having your health outcomes tracked in this pregnancy outcomes registry **You may NOT be eligible if...** - You have not consented to join the registry - You received Exablate treatment for a reason other than symptomatic fibroids Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEBody System - Functional

MR-Guided Focused Ultrasound


Locations(6)

UCLA

Los Angeles, California, United States

Stanford University

Stanford, California, United States

Mayo Clinic

Rochester, Minnesota, United States

Huashan Hospital Affiliated to Fudan University

Shanghai, China

Shanghai No. 1 Hospital

Shanghai, China

Shanghai No.1 Hospital

Shanghai, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05386615


Related Trials